July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Optic Nerve Vessel Density in Glaucoma Patients of African and European descent
Brandon Wong; Sasan Moghimi; Linda M Zangwill; Huiyuan Hou; Rafaella Penteado; Patricia Manalastas; Elham Ghahari; Christopher Bowd; Robert N Weinreb
Author Affiliations & Notes
  • Brandon Wong
    Ophthalmology, University of California, San Diego Shiley Eye Institute, San Diego, California, United States
  • Sasan Moghimi
    Ophthalmology, University of California, San Diego Shiley Eye Institute, San Diego, California, United States
  • Linda M Zangwill
    Ophthalmology, University of California, San Diego Shiley Eye Institute, San Diego, California, United States
  • Huiyuan Hou
    Ophthalmology, University of California, San Diego Shiley Eye Institute, San Diego, California, United States
  • Rafaella Penteado
    Ophthalmology, University of California, San Diego Shiley Eye Institute, San Diego, California, United States
  • Patricia Manalastas
    Ophthalmology, University of California, San Diego Shiley Eye Institute, San Diego, California, United States
  • Elham Ghahari
    Ophthalmology, University of California, San Diego Shiley Eye Institute, San Diego, California, United States
  • Christopher Bowd
    Ophthalmology, University of California, San Diego Shiley Eye Institute, San Diego, California, United States
  • Robert N Weinreb
    Ophthalmology, University of California, San Diego Shiley Eye Institute, San Diego, California, United States
  • Footnotes
    Commercial Relationships   Brandon Wong, None; Sasan Moghimi, None; Linda Zangwill, Carl Zeiss Meditec (F), Heidelberg Engineering (F), National Eye Institute (F), Optovue (F), Topcon (F); Huiyuan Hou, None; Rafaella Penteado, None; Patricia Manalastas, None; Elham Ghahari, None; Christopher Bowd, None; Robert Weinreb, Aerie (C), Alcon (C), Allergan (C), Bausch & Lomb (C), Carl Zeiss Meditec (F), Eyenovia (C), Genentech (F), Heidelberg Engineering (F), Konan (F), National Eye Institute (F), Novartis (C), Optos (F), Optovue (F), Tomey (F), Topcon (F), Unity (C)
  • Footnotes
    Support  P30 EY022589, Research to Prevent Blindness, EY11008, EY19869, EY14267, EY027510, EY026574, EY022039, EY027945, EY029058
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6180. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Optic Nerve Vessel Density in Glaucoma Patients of African and European descent
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Brandon Wong, Sasan Moghimi, Linda M Zangwill, Huiyuan Hou, Rafaella Penteado, Patricia Manalastas, Elham Ghahari, Christopher Bowd, Robert N Weinreb; Optic Nerve Vessel Density in Glaucoma Patients of African and European descent. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6180.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose : To evaluate racial differences in optic nerve head (ONH) vessel density parameters measured by optical coherence tomography angiography (OCTA) in patients with open-angle glaucoma

Methods : 326 eyes of 199 glaucoma patients, and 100 eyes of 58 healthy subjects from the Diagnostic Innovations in Glaucoma Study with OCTA images were included. Circumpapillary capillary density (cpCD), and 6 Garway-Heath sectors were measured after removing the large vessels from OCTA images. Pattern of vessel density loss in European-descent (ED) and African-descent (AD) participants were explored and areas under the receiver operating characteristic curves (AUROC) were used to evaluate diagnostic accuracy in each ethnic group after adjusting for confounders.

Results : AD and ED subjects with glaucoma had comparable age and visual field MD (mean deviation). After adjusting for age, disc area and other confounders, significant lower cpCD was found in ED eyes compared to AD in early glaucoma (44.97±5.04 and 48.59±4.32 %, respectively; P <0.001) and moderate to advanced glaucoma (33.93±6.61 and 39.08±6.61 %, respectively; P=0.001). Although estimated vessel density loss was greater in all sectors in ED subjects, similar pattern of density loss was observed in both racial group with temporal sector being the least affected region. Lower MD and older age were associated with lower cpCD in both ethnicities in multivariable model. The AUROC of cpCD for discriminating between healthy and glaucomatous eyes was higher for ED (0.88) compared to AD (0.69) (p=0.003).

Conclusions : A significantly lower cpCD in ED subjects was found compared to AD subjects in eyes with similar severity of glaucoma. Although ONH vessel density parameters had a good diagnostic ability in detecting glaucoma in ED, their ability was modest in AD patients.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Attribution-NonCommercial-NoDerivatives
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept